DD
DuPont de Nemours, Inc.
Next earnings Aug 3, 2026 · consensus $0.61 EPS, $1.86B rev
Last earnings +8.4% on 2026-05-05
$139.91
▲ +3.07%$139.91▲ +413.06%
over 1Y
L $27.16H $139.91
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.1%
1W+1.5%
1M+187.5%
3M+211.3%
YTD+250.6%
1Y+413.1%
Hold
Conviction
Horizon
Long (>12mo)
Street · 25 analysts
Buy
A DuPont mid-breakup — clean balance sheet and dividend, but a transformation-driven loss and an 8.2x sales tag say own it, don't chase it.
Price / Sales 8.2 · market cap / FY2025 revenue
DD is not the company its trailing numbers describe. The FY2025 10-K confirms a wholesale reshaping: the Electronics Business was spun off as Qnity on Nov 1 2025, the ~$1.2B Aramids sale to Arclin/TJC was set to close around Q1 2026, and these follow the earlier M&M and Delrin divestitures. That is why reported revenue collapsed from ~$13.0B (FY2022) to ~$6.6–6.85B (FY2023–25) and why FY2025 swung to a -$779M net loss (diluted EPS -$1.86) despite revenue actually ticking up +1.9% — the loss reflects discontinued-operations accounting and separation costs, not a core-business implosion. The accumulated deficit of -$24.3B is a legacy artifact of the DowDuPont split history, not fresh cash burn.
The balance sheet of the remaining DuPont (Healthcare & Water Technologies + Diversified Industrials) is sound: $13.9B equity against $7.47B total liabilities (0.54x liabilities/equity), current assets $5.58B vs current liabilities $2.31B, and zero current debt maturity. MD&A cites $1.7B net working capital and management's view that operating cash flow plus debt-market access cover liquidity needs. The company still generated $560M operating cash flow and funded a $597M dividend in FY2025. This is a financially stable, deleveraging industrial — not a distressed name.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 7:41 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $12.6B | $13.0B | $6.61B | $6.72B | $6.85B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $6.47B | $5.87B | $423M | $703M | -$779M |
| Diluted EPS | $11.89 | $11.75 | $0.94 | $1.68 | -$1.86 |
| Net margin | 51.5% | 45.1% | 6.4% | 10.5% | -11.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$26.0B
EV / EBITDA—
EV / Sales3.8
EV / FCF114.7
P / FCF83.2
PEG (trailing)—
Earnings yield-4.1%
FCF yield1.2%
Quality & risk
ROIC (est.)—
Free cash flow$227M
Total debt$7.86B
Net cash-$7.14B
Piotroski F-Score5/9
Capital returns
Buyback yield11.3%
Dividend yield (est.)3.2%
Shareholder yield14.5%
Shares Δ YoY-2.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
- 8-K Material event2026-06-24
Charter/bylaw amendments modified shareholder rights (post-spin cleanup)
- 8-K Shareholder vote2026-05-26
Annual meeting vote results + Reg FD disclosure
- 8-K Earnings results2026-05-05
Q1 2026 10-Q: first full quarter as standalone post-Qnity DuPont
- 10-Q Quarterly report2026-05-05
Q1 2026 10-Q: first full quarter as standalone post-Qnity DuPont
- 8-K Officer / director change2026-04-15
Officer/director leadership change announced
- DEF 14A Proxy statement2026-04-10
Annual proxy: board slate, exec comp, say-on-pay vote
- 8-K Other event2026-03-18
Other-events update, likely Aramids divestiture closing (~$1.2B)
- 8-K Reg FD disclosure2026-03-16
Reg FD disclosure (investor presentation/update)
- 10-K Annual report2026-02-17
FY2025: net loss $779M; completed Qnity electronics spinoff
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-232026-06-24open ↗11-KPeriod ending 2025-12-312026-06-12open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-292026-06-02open ↗4Period ending 2026-05-292026-06-02open ↗4Period ending 2026-05-292026-06-02open ↗SDFiling2026-06-01open ↗4Period ending 2026-05-212026-05-28open ↗4Period ending 2026-05-212026-05-28open ↗4Period ending 2026-05-212026-05-28open ↗4Period ending 2026-05-212026-05-28open ↗
Frequently asked
- Is DuPont de Nemours, Inc. (DD) a buy?
- DD currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. A DuPont mid-breakup — clean balance sheet and dividend, but a transformation-driven loss and an 8.2x sales tag say own it, don't chase it.
- What is DuPont de Nemours, Inc.'s quality score?
- DD scores 51.43537025774085/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001666700, latest 10-Q filed 2026-05-05) · EODHD · Proprietary analysis · as of 6/25/2026, 11:41:37 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.